ArticleARYA atherosclerosis2016
Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension.
Article in ARYA atherosclerosis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.
- Measurement Properties of Patient-Reported Outcome Measures for Medication Adherence in Cardiovascular Disease: A COSMIN Systematic Review.Clinical drug investigation · 2022Pooled it
- Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature.Journal of hypertension · 2020Pooled it
- Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties.International journal of clinical pharmacy · 2020Pooled it
- The effect of self-care, self-efficacy, and health literacy on health-related quality of life in patients with hypertension: a cross-sectional study.BMC public health · 2025Article
- Medication adherence scales in non-communicable diseases: A scoping review of design gaps, constructs and validation processes.PloS one · 2025Article
- Tele-Medical Nutrition Therapy to Promote Healthy Eating and Nutrition Adherence of Chronic Patients in the COVID-19 Pandemic: A Pragmatically Before-After Trial.Health science reports · 2024Article
- Medications Non-adherence Reasoning Scale (MedNARS): Development and psychometric properties appraisal.Health promotion perspectives · 2023Article
- Translation, Cultural Adaptation and Validation of the Hill Bone Compliance to High Blood Pressure Therapy Scale to Nepalese Language.Patient preference and adherence · 2022Article
- The psychometric properties of the Hypertensive Treatment Adherence Scale.ARYA atherosclerosis · 2020Article
- Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertension.Investigacion y educacion en enfermeria · 2019Article
- Psychometrics of the Persian Version of the Team Assessment Questionnaire in Providing Care for Heart Failure Patients.Iranian journal of nursing and midwifery researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is a global public health crisis. Poorly controlled high blood pressure is one of the major factors contributed to this crisis. As lack of treatment adherence is often considered the main reason for this failure, the Treatment Adherence Questionnaire for Patient with Hypertension (TAQPH) was developed. Since this questionnaire should be reliable and strongly valid to be used in clinics and research, this study was performed to test the reliability and validity of the TAQPH.
methodsA cross-sectional study was conducted to validate the Persian version of TAQPH after using a modified forward/backward translation procedure. A total of 330 hypertensive patients were participated in this study. Construct and criterion validity, Cronbach¢s alpha, and test-retest reliability were used to validate the Persian scale.
resultsData analysis showed that the scale had excellent stability (intraclass correlation = 0.95) and good acceptability of internal consistency (α = 0.80). The exploratory factor analysis (EFA) was meaningful but was not confirmed with confirmatory factor analysis (CFA). The scale score was correlated with Morisky Medication Adherence Scale (MMAS) score (Ρ = 0.27).
conclusionIn total, most of the psychometric properties of the 25-item P-TAQHP achieved the standard level and were sufficient to recommend for general use.
Indexed as
Identifiers
27429627PMC4933746W2301211539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.